Literature DB >> 16234331

One hundred years of research in the pathogenesis of pulmonary hypertension.

Ari Zaiman1, Iwona Fijalkowska, Paul M Hassoun, Rubin M Tuder.   

Abstract

Entities:  

Mesh：

Year:  2005        PMID： 16234331      PMCID： PMC2715349          DOI： 10.1165/rcmb.F307

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN： 1044-1549            Impact factor:   6.914


× No keyword cloud information.
  58 in total

1.  Hypoxia-induced pulmonary vascular remodeling: a model for what human disease?

Authors:  N F Voelkel; R M Tuder
Journal:  J Clin Invest       Date:  2000-09       Impact factor: 14.808

2.  Gene microarray analysis of peripheral blood cells in pulmonary arterial hypertension.

Authors:  Todd M Bull; Christopher D Coldren; Mark Moore; Sylk M Sotto-Santiago; David V Pham; S Patrick Nana-Sinkam; Norbert F Voelkel; Mark W Geraci
Journal:  Am J Respir Crit Care Med       Date:  2004-06-23       Impact factor: 21.405

3.  Direct role for potassium channel inhibition in hypoxic pulmonary vasoconstriction.

Authors:  J M Post; J R Hume; S L Archer; E K Weir
Journal:  Am J Physiol       Date:  1992-04

4.  Serotonin uptake by bovine pulmonary artery endothelial cells in culture. II. Stimulation by hypoxia.

Authors:  S L Lee; B L Fanburg
Journal:  Am J Physiol       Date:  1986-05

5.  Monoclonal endothelial cell proliferation is present in primary but not secondary pulmonary hypertension.

Authors:  S D Lee; K R Shroyer; N E Markham; C D Cool; N F Voelkel; R M Tuder
Journal:  J Clin Invest       Date:  1998-03-01       Impact factor: 14.808

6.  Expression of angiogenesis-related molecules in plexiform lesions in severe pulmonary hypertension: evidence for a process of disordered angiogenesis.

Authors:  R M Tuder; M Chacon; L Alger; J Wang; L Taraseviciene-Stewart; Y Kasahara; C D Cool; A E Bishop; M Geraci; G L Semenza; M Yacoub; J M Polak; N F Voelkel
Journal:  J Pathol       Date:  2001-10       Impact factor: 7.996

7.  Rescue of monocrotaline-induced pulmonary arterial hypertension using bone marrow-derived endothelial-like progenitor cells: efficacy of combined cell and eNOS gene therapy in established disease.

Authors:  Yidan D Zhao; David W Courtman; Yupu Deng; Lakshmi Kugathasan; Qiuwang Zhang; Duncan J Stewart
Journal:  Circ Res       Date:  2005-02-03       Impact factor: 17.367

8.  Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension.

Authors:  A Giaid; D Saleh
Journal:  N Engl J Med       Date:  1995-07-27       Impact factor: 91.245

9.  Pulmonary microvascular and macrovascular endothelial cells: differential regulation of Ca2+ and permeability.

Authors:  J J Kelly; T M Moore; P Babal; A H Diwan; T Stevens; W J Thompson
Journal:  Am J Physiol       Date:  1998-05

10.  Smooth muscle-mediated connective tissue remodeling in pulmonary hypertension.

Authors:  R P Mecham; L A Whitehouse; D S Wrenn; W C Parks; G L Griffin; R M Senior; E C Crouch; K R Stenmark; N F Voelkel
Journal:  Science       Date:  1987-07-24       Impact factor: 47.728
View more
  26 in total

1.  Targeting energetic metabolism: a new frontier in the pathogenesis and treatment of pulmonary hypertension.

Authors:  Rubin M Tuder; Laura A Davis; Brian B Graham
Journal:  Am J Respir Crit Care Med       Date:  2011-11-10       Impact factor: 21.405

Review 2.  Pathology of pulmonary hypertension.

Authors:  Rubin M Tuder; John C Marecki; Amy Richter; Iwona Fijalkowska; Sonia Flores
Journal:  Clin Chest Med       Date:  2007-03       Impact factor: 2.878

Review 3.  Therapeutic applications of sildenafil citrate in the management of paediatric pulmonary hypertension.

Authors:  Leah Leibovitch; Ilan Matok; Gideon Paret
Journal:  Drugs       Date:  2007       Impact factor: 9.546

4.  Drug discovery in pulmonary arterial hypertension: attacking the enigmatic root of a deadly weed.

Authors:  R James White; Katie L Lannan; Richard P Phipps
Journal:  Drug Discov Today       Date:  2014-04-21       Impact factor: 7.851

5.  Linking new and old concepts: inflammation meets the Warburg phenomenon in pulmonary arterial hypertension.

Authors:  Todd M Kolb; Rachel L Damico; Paul M Hassoun
Journal:  J Mol Med (Berl)       Date:  2011-08       Impact factor: 4.599

6.  Resistin-Like Molecule α in Allergen-Induced Pulmonary Vascular Remodeling.

Authors:  Chunling Fan; Lucas W Meuchel; Qingning Su; Daniel J Angelini; Ailan Zhang; Chris Cheadle; Irina Kolosova; Oleg D Makarevich; Kazuyo Yamaji-Kegan; Marc E Rothenberg; Roger A Johns
Journal:  Am J Respir Cell Mol Biol       Date:  2015-09       Impact factor: 6.914

Review 7.  Perspective: pathobiological paradigms in pulmonary hypertension, time for reappraisal.

Authors:  Rubin M Tuder; Kurt R Stenmark
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2020-03-18       Impact factor: 5.464

Review 8.  Role of somatic mutations in vascular disease formation.

Authors:  Sarah M Weakley; Jun Jiang; Panagiotis Kougias; Peter H Lin; Qizhi Yao; F Charles Brunicardi; Richard A Gibbs; Changyi Chen
Journal:  Expert Rev Mol Diagn       Date:  2010-03       Impact factor: 5.225

9.  Mechanical characteristics of the pulmonary artery in beagle dogs with hepatopulmonary syndrome and portopulmonary hypertension.

Authors:  Guozhen Yan; Junfeng He; Yueli Yu; Yang Liu; Yanfen Yuan; Zhiyong Guo
Journal:  Biomed Rep       Date:  2015-10-06

Review 10.  Genetically manipulated mouse models of lung disease: potential and pitfalls.

Authors:  Rebecca M Baron; Alexander J S Choi; Caroline A Owen; Augustine M K Choi
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-12-23       Impact factor: 5.464
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.